Your browser doesn't support javascript.
loading
A Pathology-Based Combined Model to Identify PAM50 Non-luminal Intrinsic Disease in Hormone Receptor-Positive HER2-Negative Breast Cancer.
Pascual, Tomás; Martin, Miguel; Fernández-Martínez, Aranzazu; Paré, Laia; Alba, Emilio; Rodríguez-Lescure, Álvaro; Perrone, Giuseppe; Cortés, Javier; Morales, Serafín; Lluch, Ana; Urruticoechea, Ander; González-Farré, Blanca; Galván, Patricia; Jares, Pedro; Rodriguez, Adela; Chic, Nuria; Righi, Daniela; Cejalvo, Juan Miguel; Tonini, Giuseppe; Adamo, Barbara; Vidal, Maria; Villagrasa, Patricia; Muñoz, Montserrat; Prat, Aleix.
Afiliação
  • Pascual T; Medical Oncology Department, Hospital Clinic de Barcelona, Barcelona, Spain.
  • Martin M; SOLTI Breast Cancer Research Group, Barcelona, Spain.
  • Fernández-Martínez A; Medical Oncology Department, Hospital Gregorio Marañón, Universidad Complutense, Madrid, Spain.
  • Paré L; GEICAM (Spanish Breast Cancer Group), Madrid, Spain.
  • Alba E; Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Madrid, Spain.
  • Rodríguez-Lescure Á; Department of Genetics, University of North Carolina, Chapel Hill, NC, United States.
  • Perrone G; Medical Oncology Department, Hospital Clinic de Barcelona, Barcelona, Spain.
  • Cortés J; SOLTI Breast Cancer Research Group, Barcelona, Spain.
  • Morales S; GEICAM (Spanish Breast Cancer Group), Madrid, Spain.
  • Lluch A; Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Madrid, Spain.
  • Urruticoechea A; Medical Oncology Department, Hospital Universitario Virgen de la Victoria, IBIMA, Málaga, Spain.
  • González-Farré B; GEICAM (Spanish Breast Cancer Group), Madrid, Spain.
  • Galván P; Medical Oncology Department, Hospital Universitario de Elche, Elche, Spain.
  • Jares P; Department of Medicine, Università Campus Bio-Medico di Roma, Rome, Italy.
  • Rodriguez A; IOB Institute of Oncology, Quironsalud Group, Madrid, Spain.
  • Chic N; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Righi D; Medical Oncology Department, Hospital Arnau de Vilanova, Lleida, Spain.
  • Cejalvo JM; GEICAM (Spanish Breast Cancer Group), Madrid, Spain.
  • Tonini G; Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Madrid, Spain.
  • Adamo B; Medical Oncology Department, Hospital Clinico Universitario, Valencia, Spain.
  • Vidal M; Biomedical Research Institute INCLIVA, Valencia, Spain.
  • Villagrasa P; Department of Medicine, Universitat de València, Valencia, Spain.
  • Muñoz M; Department of Medical Oncology, Fundación Onkologikoa, Donostia, Spain.
  • Prat A; SOLTI Breast Cancer Research Group, Barcelona, Spain.
Front Oncol ; 9: 303, 2019.
Article em En | MEDLINE | ID: mdl-31106144
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Front Oncol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Espanha País de publicação: Suíça
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Front Oncol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Espanha País de publicação: Suíça